A healthcare professional can provide personalised guidance based on current evidence, discuss approved alternatives, and advise on eligibility for clinical trials if appropriate
Retatrutide, a powerful experimental weight-loss drug that mimics three different hormones the body produces after eating, helped people lose 70 pounds on average, or 28% of their body weight, pharmaceutical giant Eli Lilly announced on Thursday, May 21
Pancreatitis is a rare but serious risk associated with GLP-1 receptor agonists
Patients should start gradually and increase activity as tolerated, avoiding overexertion
This intestinal a-glucosidase blocker narrows postmeal glucose excursion and lowers peak glucose by changing digestion and absorption of the luminal carbohydrates
Waiting 45 weeks gets you to steady-state levels before increasing, which makes it easier to tell whether side effects come from the dose escalation or just normal fluctuation